Deficiency in coatomer complex I causes aberrant activation of STING signalling

• Published in: Nature communications Vol. 13; no. 1; p. 2321
• Main Authors: Steiner, Annemarie, Hrovat-Schaale, Katja, Prigione, Ignazia, Yu, Chien-Hsiung, Laohamonthonkul, Pawat, Harapas, Cassandra R., Low, Ronnie Ren Jie, De Nardo, Dominic, Dagley, Laura F., Mlodzianoski, Michael J., Rogers, Kelly L., Zillinger, Thomas, Hartmann, Gunther, Gantier, Michael P., Gattorno, Marco, Geyer, Matthias, Volpi, Stefano, Davidson, Sophia, Masters, Seth L.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 28.04.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 13/1; 13/106; 13/31; 13/44; 631/250/249/2510/2511; 631/250/256; 631/250/262/2106; 631/250/262/2106/2518; Cell lines; Chronic obstructive pulmonary disease; Coat Protein Complex I - metabolism; COP-Coated Vesicles - metabolism; Deoxyribonucleic acid; DNA; Electron Transport Complex I - metabolism; Endoplasmic reticulum; Golgi apparatus; Humanities and Social Sciences; Humans; Immunosensors; Inflammatory diseases; Interferon; Leukocytes (mononuclear); Leukocytes, Mononuclear - metabolism; multidisciplinary; Mutation; Nucleotidyltransferases - genetics; Nucleotidyltransferases - metabolism; Peripheral blood mononuclear cells; Science; Science (multidisciplinary); Signal Transduction; Signaling
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-022-29946-6

Coatomer complex I (COPI) mediates retrograde vesicular trafficking from Golgi to the endoplasmic reticulum (ER) and within Golgi compartments. Deficiency in subunit alpha causes COPA syndrome and is associated with type I IFN signalling, although the upstream innate immune sensor involved was unknown. Using in vitro models we find aberrant activation of the STING pathway due to deficient retrograde but probably not intra-Golgi transport. Further we find the upstream cytosolic DNA sensor cGAS as essentially required to drive type I IFN signalling. Genetic deletion of COPI subunits COPG1 or COPD similarly induces type I IFN activation in vitro, which suggests that inflammatory diseases associated with mutations in other COPI subunit genes may exist. Finally, we demonstrate that inflammation in COPA syndrome patient peripheral blood mononuclear cells and COPI-deficient cell lines is ameliorated by treatment with the small molecule STING inhibitor H-151, suggesting targeted inhibition of the cGAS/STING pathway as a promising therapeutic approach. Mutations in the coatomer complex I can result in endoplasmic reticulum stress and inflammatory consequences. Here authors define aberrant activation of the STING immunosensing pathway in a disturbed coatmer complex context and the therapeutic modulation of this axis to counter the associated immunopathology.